Macalisang, Roel E.

HRN: 21-29-87  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2022
MUPIROCIN 2%, 15G (TUBE)
05/05/2022
05/12/2022
TOPICAL
Apply Thinly To Affected Areas
Bid
Multiple Abrasions
Waiting Final Action 
05/17/2022
CEFTRIAXONE 1G (VIAL)
05/17/2022
05/24/2022
IV
1g
Q12h
Fracture
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: